Internal Medicine · Duarte, CA
NPI
1285825414
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 East Duarte Rd
Duarte, CA, 91010
Phone (626) 471-9200
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
1,388 services
Medicare patients, 2024
26
Average age 64
Drug cost, 2024
$4.7M
1,433 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Tomoko Tagawa prescribed most often to Medicare patients was Anastrozole, with 181 prescriptions and refills. In total Tomoko Tagawa wrote 1,433 Medicare prescriptions that cost $4.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 181 | 537 | 63 | $5,027 |
| Acyclovir Generic | 88 | 108 | 17 | $1,339 |
| Prednisone Generic | 81 | 127 | 21 | $735 |
| Dexamethasone Generic | 79 | 104 | 34 | $1,282 |
| Abiraterone Acetate Generic | 69 | 78 | Under 11 | $12K |
| Ondansetron Odt Ondansetron | 57 | 58 | 38 | $847 |
| Pomalyst Pomalidomide | 52 | 52 | Under 11 | $1.2M |
| Lenalidomide Generic | 48 | 48 | 13 | $433K |
| Nivestym Filgrastim-Aafi | 43 | 43 | 15 | $45K |
| Everolimus Generic | 37 | 37 | Under 11 | $22K |
| Eliquis Apixaban | 36 | 58 | Under 11 | $35K |
| Pantoprazole Sodium Generic | 35 | 42 | Under 11 | $367 |
| Xtandi Enzalutamide | 34 | 34 | Under 11 | $415K |
| Brukinsa Zanubrutinib | 26 | 26 | Under 11 | $304K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 23 | 23 | Under 11 | $907 |
Brand drugs: - claims; generic drugs: 1,025 claims; opioid claims: 48.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Tomoko Tagawa were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.